NO329470B1 - Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter - Google Patents

Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter Download PDF

Info

Publication number: NO329470B1
Authority: NO; Norway
Prior art keywords: warts; treatment; preparation; formic acid; wart
Prior art date: 1999-01-21

Application number

NO20013605A

Other languages

English (en)

Norwegian (no)

Other versions

NO20013605L (no

NO20013605D0 (no

Inventor

Astrid Agholme

Original Assignee

Astrid Agholme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-21

Filing date

2001-07-20

Publication date

2010-10-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20414173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO329470(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-07-20 Application filed by Astrid Agholme filed Critical Astrid Agholme

2001-07-20 Publication of NO20013605D0 publication Critical patent/NO20013605D0/no

2001-09-20 Publication of NO20013605L publication Critical patent/NO20013605L/no

2010-10-25 Publication of NO329470B1 publication Critical patent/NO329470B1/no

Links

BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 title claims description 43
238000011282 treatment Methods 0.000 title claims description 35
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 title claims description 21
235000019253 formic acid Nutrition 0.000 title claims description 21
239000003814 drug Substances 0.000 title claims description 8
239000000203 mixture Substances 0.000 title claims description 3
238000004519 manufacturing process Methods 0.000 title claims 2
238000009472 formulation Methods 0.000 title 1
208000000260 Warts Diseases 0.000 claims description 74
201000010153 skin papilloma Diseases 0.000 claims description 74
238000002360 preparation method Methods 0.000 claims description 38
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
150000001875 compounds Chemical class 0.000 claims description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
241000124008 Mammalia Species 0.000 claims description 4
241001631646 Papillomaviridae Species 0.000 claims description 4
238000011200 topical administration Methods 0.000 claims description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
239000003921 oil Substances 0.000 claims description 2
238000000034 method Methods 0.000 description 9
241000700605 Viruses Species 0.000 description 8
230000000694 effects Effects 0.000 description 7
235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 3
240000003259 Brassica oleracea var. botrytis Species 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
239000000126 substance Substances 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
229940079593 drug Drugs 0.000 description 2
230000008014 freezing Effects 0.000 description 2
238000007710 freezing Methods 0.000 description 2
230000035876 healing Effects 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
206010002091 Anaesthesia Diseases 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
206010020649 Hyperkeratosis Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000012050 conventional carrier Substances 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000001035 drying Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000002674 ointment Substances 0.000 description 1
230000036407 pain Effects 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
239000011505 plaster Substances 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000037390 scarring Effects 0.000 description 1
239000002884 skin cream Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20013605A 1999-01-21 2001-07-20 Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter NO329470B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9900177A SE513436C2 (sv)	1999-01-21	1999-01-21	Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
PCT/SE2000/000088 WO2000045808A1 (en)	1999-01-21	2000-01-18	Preparation for warts

Publications (3)

Publication Number	Publication Date
NO20013605D0 NO20013605D0 (no)	2001-07-20
NO20013605L NO20013605L (no)	2001-09-20
NO329470B1 true NO329470B1 (no)	2010-10-25

Family

ID=20414173

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20013605A NO329470B1 (no)	1999-01-21	2001-07-20	Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter

Country Status (9)

Country	Link
US (1)	US6503946B1 (de)
EP (1)	EP1143966B1 (de)
AT (1)	ATE249820T1 (de)
AU (1)	AU2337900A (de)
DE (1)	DE60005299T2 (de)
ES (1)	ES2207486T3 (de)
NO (1)	NO329470B1 (de)
SE (1)	SE513436C2 (de)
WO (1)	WO2000045808A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7128903B2 (en) *	2001-10-03	2006-10-31	Innovative Pharmaceutical Concepts (Ipc) Inc.	Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
BG106215A (bg) *	2001-12-12	2003-06-30	ПАНЧЕВ Владимир	Средство за радикално лечение на туморите, възпалителни процеси, гъбични образувания и други изменения на тъканите, диагностика и профилактика и методи за прилагането му
SI2431030T1 (sl) *	2010-09-17	2016-03-31	Abbell Ab	Zdravljenje glivičnih okužb
SI2460509T1 (en)	2010-12-06	2018-03-30	Abbex Ab	A composition for the treatment of warts
US10716857B2 (en) *	2012-05-28	2020-07-21	Abbex Ab	Composition for treatment of warts
EP2692332B1 (de) *	2012-05-29	2019-08-21	Unigroup ApS	Zusammensetzung zur Behandlung von Callus, Hühneraugen und Psoriasis
FR3018687B1 (fr) *	2014-03-19	2017-04-14	Patrick Lepeytre	" composition a base d'acides carboxyliques et son application pour le traitement des hyperkeratoses " -
EP3265166A1 (de)	2015-03-06	2018-01-10	Medical Brands Research B.V.	Applikator
EP3205340A1 (de) *	2016-02-10	2017-08-16	Winko Beheer B.V.	Zusammensetzung zur behandlung von hautleiden

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LU86573A1 (de) *	1986-09-08	1988-04-05	Chimicasa Gmbh	Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen
EP0527241B1 (de)	1991-07-15	1994-03-16	Artesan Pharma Gesellschaft mit beschränkter Haftung	Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
GB9621990D0 (en) *	1996-10-22	1996-12-18	Scotia Pharma Ltd	Use
DE19736265C2 (de)	1997-08-15	2002-10-31	Phytexpert Pharm Tox Consultin	Arzneimittel zur Behandlung von Hauterkrankungen

1999
- 1999-01-21 SE SE9900177A patent/SE513436C2/sv not_active IP Right Cessation
2000
- 2000-01-18 EP EP00902251A patent/EP1143966B1/de not_active Expired - Lifetime
- 2000-01-18 US US09/889,740 patent/US6503946B1/en not_active Expired - Lifetime
- 2000-01-18 DE DE60005299T patent/DE60005299T2/de not_active Expired - Lifetime
- 2000-01-18 AT AT00902251T patent/ATE249820T1/de not_active IP Right Cessation
- 2000-01-18 ES ES00902251T patent/ES2207486T3/es not_active Expired - Lifetime
- 2000-01-18 WO PCT/SE2000/000088 patent/WO2000045808A1/en not_active Ceased
- 2000-01-18 AU AU23379/00A patent/AU2337900A/en not_active Abandoned
2001
- 2001-07-20 NO NO20013605A patent/NO329470B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
SE513436C2 (sv)	2000-09-11
EP1143966B1 (de)	2003-09-17
NO20013605L (no)	2001-09-20
SE9900177L (sv)	2000-07-22
AU2337900A (en)	2000-08-25
WO2000045808A1 (en)	2000-08-10
SE9900177D0 (sv)	1999-01-21
DE60005299D1 (de)	2003-10-23
EP1143966A1 (de)	2001-10-17
ATE249820T1 (de)	2003-10-15
ES2207486T3 (es)	2004-06-01
NO20013605D0 (no)	2001-07-20
DE60005299T2 (de)	2004-07-01
US6503946B1 (en)	2003-01-07

Legal Events

Date

Code

Title

Description

2014-08-25

MM1K

Lapsed by not paying the annual fees

2016-02-01

BDEC

Board of appeal decision

Free format text: KLAGEN FORKASTES

Effective date: 20151012

Publication	Publication Date	Title
US5411738A (en)	1995-05-02	Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
Gajraj et al.	1994	Eutectic mixture of local anesthetics (EMLA®) cream
US5709869A (en)	1998-01-20	Method for treating nerve injury pain associated with shingles
RU2523889C2 (ru)	2014-07-27	Применение фармацевтических композиций в изготовлении лекарственных средств для лечения диабетических язв
US7001622B1 (en)	2006-02-21	Composition and method for treatment and prevention of pruritis
Artzi et al.	2020	A new approach in the treatment of pediatric hypertrophic burn scars: Tixel‐associated topical triamcinolone acetonide and 5‐fluorouracil delivery
Dhlamini et al.	2022	Clinical effect of photobiomodulation on wound healing of diabetic foot ulcers: does skin color needs to be considered?
US6503946B1 (en)	2003-01-07	Preparation for warts
Martini et al.	2011	Efficacy and Tolerability of Fitostimoline in Two Different Forms (Soaked Gauzes and Cream) and Citrizan Gel in the Topical Treatment of Second‐Degree Superficial Cutaneous Burns
Comeau et al.	2019	Fractionated carbon dioxide laser resurfacing as an ideal treatment option for severe rhinophyma: a case report and discussion
Kawalilak et al.	2017	Management of a facial partial thickness chemical burn in a dog caused by bleach
US9421235B2 (en)	2016-08-23	Medicine containing extracts of Ficus microcarpa for healing wounds of a diabetic patient
CN102293783B (zh)	2012-10-03	一种治疗褥疮的中药组合物
KM et al.	1998	Combined phototherapy/low intensity laser therapy in the management of diabetic ischaemic and neuropathic ulceration: a single case series investigation
Favia et al.	2025	LAT Gel: from the Galenical Laboratory to the Paediatric Emergency Room–A Fondazione Policlinico Gemelli IRCCS Experience
RU2849260C1 (ru)	2025-10-23	Способ купирования нейропатической боли (варианты)
RU2467719C2 (ru)	2012-11-27	Способ лечения невралгии тройничного нерва
US6395779B1 (en)	2002-05-28	Method of treatment using peroxidized lipids
Schmidt	1976	Warts: their diagnosis and treatment
Bihari et al.	2023	Assessment of the Effectiveness of Jalaukavacharana (Leech therapy) and Shalmali Kantaka Lepa in a Mukhadushika (Acne Vulgaris): A Case Study
RU2286791C1 (ru)	2006-11-10	Способ лечения рубцов
Hussain et al.	2015	Treatment options for managing non‐genital warts
Senthiarasi	2023	Ayurvedic management of Agnidagdha vrana (burn wound) in a child: A case report
JPS6257566A (ja)	1987-03-13	水虫治療用塗布剤
Hakim et al.	2013	Wound management in the presence of peripheral arterial disease